account_balanceBalance Sheet (BS) Summary

Updated: 03/31/20262026 Q1

Total Assets

1.3B USD

YoY +81.1%

Shareholders' Equity

1.3B USD

YoY +86.5%

Equity Ratio

97.1%

YoY +2.8pt

Book Value Per Share

18.03USD

YoY +55.8%

Asset & Liability Mix

Non-current AssetsCurrent AssetsEquityNon-current LiabilitiesCurrent Liabilities

Equity Ratio Trend (5 Years)

Unit: %

200150100500

2022

2023

2024

2025

Balance Sheet Details

Unit: USD

Item

2022

2023

2024

2025

Cash

Cash and Equivalents

Short-term Investments

Net Receivables

Inventory

Other Current Assets

Total Current Assets

131.55M

598.64M

5.96M

0

605,000

741.36M

Goodwill

Intangible Assets

Property, Plant and Equipment

Property, Plant and Equipment Net

Long-term Investments

Other Assets

Other Non-current Assets

Net Tangible Assets

Non-current Assets Total

Total Assets

0

14.38M

0

181.40M

937.13M

195.78M

937.13M

Accounts Payable

Short-term Debt

Short/Current Long-term Debt

Current Deferred Revenue

Other Current Liabilities

Total Current Liabilities

1.22M

0

3.66M

27.91M

Long-term Debt

Long-term Debt Total

Capital Lease Obligations

Other Non-current Liabilities

Net Debt

Non-current Liabilities Total

Total Liabilities

5.34M

8.85M

3.50M

0

-122.70M

5.34M

33.25M

Common Stock

Common Stock Shares Outstanding

Additional Paid-in Capital

Retained Earnings

Accumulated Other Comprehensive Income

Other Stockholder Equity

Treasury Stock

Total Stockholder Equity

1,000

60.69M

1.46B

-561.76M

1.08M

0

903.88M

Unlock Long-Term Balance Sheet Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan

Apogee Therapeutics, Inc.

account_balanceBalance Sheet (BS) Summary

Asset & Liability Mix

Equity Ratio Trend (5 Years)

Balance Sheet Details

Unlock Long-Term Balance Sheet Data